IOCB Prague

IOCB Prague, established in 1953, is a distinguished research institute operating under the Czech Academy of Sciences. It focuses on organic chemistry, biochemistry, and related fields, with a strong emphasis on applications in medicine and environmental science. The institute has made significant contributions to global health, notably in the development of critical drugs targeting HIV and HBV. Its commitment extends to academic excellence, actively participating in university education by supervising master's and doctoral theses, fostering the next generation of scientists.

With a substantial workforce of 500 - 1,000 employees, IOCB Prague maintains a significant operational scale. The institute generates an annual revenue of $39.1M, underscoring its financial stability and research output. It is recognized for its internationally recognized scientific work, producing essential reference standards and specialized substances. For insights into the expertise driving these advancements, one can explore Meet IOCB Prague's team. This dedicated team of scientists and researchers ensures the institute remains at the forefront of chemical and biological innovation.

IOCB Prague's product and service portfolio includes coordinating research efforts, providing scientific reference standards, and developing specialized proteins for various applications, including sequencing. Its B2B focus and European presence are highlighted by its extensive scientific and engineering capabilities, supported by numerous hashtags indicating deep expertise in these areas. The institute's long history, dating back to 1953, reflects a sustained commitment to pioneering research and development in its specialized domains.